The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Skeletal aspects of Gaucher disease: a review
Abstract
In Gaucher disease, a genetic deficiency in the activity of the lysosomal enzyme beta-glucocerebrosidase (acid beta-glucosidase) causes monocytes and macrophages to store excessive amounts of glucocerebroside in lysosomes. The resulting distended cells are called Gaucher cells, and the pathology associated with this condition stems from the accumulation of Gaucher cells in organ systems. The skeletal manifestations are probably the most disabling aspect of the disease. Patients commonly experience bone pain, some suffer bone crises, and up to 20% have impaired mobility. Radiological findings include Erlenmeyer flask deformity, osteopenia, osteosclerosis, osteonecrosis, fractures and bone marrow infiltration. Findings from the Gaucher Registry show that nearly all patients with Gaucher disease have radiological evidence of skeletal involvement, and the majority have a history of serious skeletal complications. Skeletal involvement follows three basic processes: focal disease (irreversible lesions such as osteonecrosis and osteosclerosis), local disease (reversible abnormalities adjacent to heavily involved marrow such as cortical thinning and long bone deformity) and generalized osteopenia. Infarctions are involved in some of the skeletal manifestations, but the mechanisms causing high rates of bone turnover and failure of remodelling are not known. The availability of a beta-glucocerebrosidase-deficient mouse model of Gaucher disease with long-term survival should help elucidate the skeletal pathology in Gaucher disease and may ultimately lead to improved management of skeletal complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of lysosomal storage disorders
Meikle, P. J. (1999) · JAMA · doi:10.1001/jama.281.3.249 · Cited by 2,197
Idiopathic bone necrosis of the femoral head. Early diagnosis and treatment
Ficat, R. (1985) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.67b1.3155745 · Cited by 1,322
Metabolism of glucocerebrosides II. Evidence of an enzymatic deficiency in Gaucher's disease
Brady, R. O., Kanfer, J. N., & Shapiro, D. (1965) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(65)90743-6 · Cited by 807
The Use of Biochemical Markers of Bone Turnover in Osteoporosis
Delmas, P. D., Eastell, R., Garnero, P., Seibel, M. J., & Stepan, J. (2000) · Osteoporosis International · doi:10.1007/s001980070002 · Cited by 722
The Gaucher Registry: Demographics and Disease Characteristics of 1698 Patients With Gaucher Disease
Charrow, J., Andersson, H. C., Kaplan, P., Kolodny, E. H., Mistry, P., Pastores, G., Rosenbloom, B. E., Scott, C. R., Wappner, R. S., Weinreb, N. J., et al. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.18.2835 · Cited by 574
Self-citationMitchell, D. G., Rao, V. M., Dalinka, M. K., Spritzer, C. E., Alavi, A. A., Steinberg, M. E., Fallon, M. D., & Kressel, H. Y. (1987) · Radiology · doi:10.1148/radiology.162.3.3809484 · Cited by 543
Clinical Utility of Biochemical Markers of Bone Remodeling
Watts, N. B. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.8.1359 · Cited by 336
Analysis and Classification of 304 Mutant Alleles in Patients with Type 1 and Type 3 Gaucher Disease
Koprivica, V., Stone, D. L., Park, J. K., Callahan, M., Frisch, A., Cohen, I. J., Tayebi, N., & Sidransky, E. (2000) · The American Journal of Human Genetics · doi:10.1086/302925 · Cited by 334
Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
Tybulewicz, V. L. J., Tremblay, M. L., LaMarca, Willemsen, R., Stubblefield, B. K., Winfield, S., Zablocka, B., Sidransky, E., Martin, B. M., Huang, S. P., et al. (1992) · Nature · doi:10.1038/357407a0 · Cited by 308
3 Gaucher's disease: clinical features and natural history
Cox, T. M., & Schofield, J. P. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80033-9 · Cited by 260
Cited by
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., Brassier, A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020441 · Cited by 868
Therapeutic goals in the treatment of Gaucher disease
Pastores, G. M., Weinreb, N. J., Aerts, H., Andria, G., Cox, T. M., Giralt, M., Grabowski, G. A., Mistry, P. K., & Tylki-Szymańska, A. (2004) · Seminars in Hematology · doi:10.1053/j.seminhematol.2004.07.009 · Cited by 422
Self-citationGBA, Gaucher Disease, and Parkinson’s Disease: From Genetic to Clinic to New Therapeutic Approaches
Riboldi, G. M., & Di Fonzo, A. B. (2019) · Cells · doi:10.3390/cells8040364 · Cited by 274
Daykin, E. C., Ryan, E., & Sidransky, E. (2021) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2021.01.002 · Cited by 77
Metadata
- Authors
- Wenstrup, R. J., Roca-Espiau, M., Weinreb, N. J., & Bembi, B.
- Venue
- The British Journal of Radiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-24
- Volume
- 75
- Issue
- suppl_1
- Pages
- A2-A12
- ISSN
- 0007-1285 (ISSN-L)
- 1748-880X
- OpenAlex
- W2120097445
- Cited by
- 273
- References
- 26
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Skeletal aspects of Gaucher disease: a review. https://app.cochat.ai/papers/10.1259/bjr.75.suppl_1.750002
- The paper
- Wenstrup, R. J., Roca-Espiau, M., Weinreb, N. J., & Bembi, B. (2002). Skeletal aspects of Gaucher disease: a review. The British Journal of Radiology. https://doi.org/10.1259/bjr.75.suppl_1.750002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.